We are Ethyl 5-bromobenzofuran-2-carboxylate CAS:84102-69-2 manufacturer and supplier in China, Pls send inquiry of to firstname.lastname@example.org of visit www.nbinno.com our official website should you have any interests
Chemical Name: Ethyl 5-bromobenzofuran-2-carboxylate
Molecular Formula: C11H9BrO3
Physical and Chemical Properties:
Density: 1.52g / cm3
Boiling point: 328.3ºC at 760 mmHg
Melting point: 60-62ºC
Flash point: 152.4ºC
Refractive index: 1.599
Appearance: Light yellow solid powder
25kg cardboard drum or according to customer specified requirements
Storage:Refrigerator.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Veratrazodone hydrochloride CAS:163521-08-2
Related News: Inceptua is a pharmaceutical company and service partner spanning throughout the product lifecycle – from comparator sourcing for clinical trials, through early access programs to licensing and commercialization for products.2-desoxi-2,2-difluoro-D-ribofuranosa-3,5-dibenzoato CAS:143157-22-6 With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.6-chloroguanine CAS:10310-21-1 With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.6940-49-4 “Our collaboration with Mankind demonstrates our commitment towards providing novel, innovative treatment options for efficient diabetes management,” Glenmark Pharmaceuticals President, India Formulations, Middle East and Africa Sujesh Vasudevan said.Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).